Retina Synthesis

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Play

Open in

27 episodes
weekly
Avg 18 min
English

Episodes 27

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.

#193
Wednesday · 12 min
Surgery for Encapsulated Cell Therapy
In this episode, we discuss the surgical technique and complications associated with implantation of an encapsulated cell therapy for MacTel 2 with Dr. Lloyd Clark from North Carolina Retina Association.
#192
September 16 · 11 min
Results of the Eyepoint LUGANO Trial
In this episode, we discuss the results of the Phase 3 Lugano Trial from Eyepoint Pharmaceuticals with Dr. Carl Regillo of Wills Eye Hospital.
#191
September 9 · 14 min
A Subcutaneous TKI for the Treatment of Neovascular AMD and Diabetic Retinopathy
In this episode we discuss the use of a subcutaneously administered tyrosine kinase inhibitor migaldendranib (D-4517.2) or MGB for the treatment of neovascular AMD and diabetic macular edema with Dr. Michael Singer from San Antonio
#190
September 2 · 34 min
Gene Therapy for Inherited Retinal Degenerations
In this episode, we review the current status of gene therapy for inherited retinal degenerations with Dr. Ninel Gregori, Professor of Clinical Ophthalmology, Bascom Palmer Eye Institute
#189
August 26 · 25 min
Faricimab Therapy for Polypoidal Choroidal Vasculopathy (PCV)
In this episode, we discuss the latest developments in faricimab therapy of polypoidal choroidal vasculopathy, with Dr. Gemmy Cheung, Head of the Medical Retina Division, at the Singapore National Eye Center.
#188
August 19 · 30 min
The ASRS ReST Commitee
In this episode, we review the work of the Research in Safety and Therapeutics (ReST)Committee of the American Society of Retinal Specialists (ASRS) with Dr. Andre Witkin, Chair of the ReST Committee, and Professor of Ophthalmology at Tufts University School of Medicine, New England Eye Center, and Ophthalmic Consultants of Boston.
#187
August 12 · 14 min
The Therapeutic Pipeline for Geographic Atrophy in AMD
In this episode, we discuss potential new treatments for geographic atrophy of age related macular degeneration with Dr. Jessica Randolph of Wagner Kapoor Institute in Richmond, Virginia.
#186
August 4 · 19 min
Hand Held Office Based ERG for Evaluating Diabetic Retinopathy
In this episode, we discuss the use of handheld ERG in the evaluating eye with diabetic retinopathy. ERG is a powerful predictive tool in assessing diabetic retinopathy. Our guest is Dr. Raj Maturi of the Midwest Eye Institute and Adjunct Associate Professor of Ophthalmology, at the Indiana University School of Medicine.
#185
July 30 · 11 min
4 Year Outcomes of Faricimab Therapy of Neovascular AMD
In this episode, we discuss the long term results of faricimab therapy of neovascular AMD with Dr. Carl Danzig of Fort Lauderdale, Florida and Affiliate Assistant Professor at the Charles Schmidt School of Medicine at Florida Atlantic University.
#184
July 21 · 11 min
5 Year Results of Pegacetacoplan Treatment of Geographic Atrophy
In this episode, we discuss 5 year results of the GALE study which demonstrated that earlier treatment with pegcetacoplan of geographic atrophy preserves more retinal tissue with Dr. Dilsher Dhoot, California Retina Consultants, Adjunct Clinical Assistant Professor Ophthalmology, Roski Eye Institute, Keck School of Medicine of USC.
#183
July 15 · 16 min
Polychoroidal Vasculopathy (PCV)
In this episode, we discuss the importance of early recognition of PCV, diagnostic techniques, and therapeutic approaches with Professor Jay Chhablani of the University of Pittsburgh.
#182
July 7 · 19 min
AREDS Vitamins and Geographic Atrophy
In this episode, we review the evidence regarding the effectiveness of AREDS vitamin supplementation in affecting the growth of geographic atrophy in age related macular degeneration.
#181
June 16 · 20 min
Intravitreal Gene Therapy for Neovascular AMD with 4D-150
In this episode, we discuss the promising results of intravitreal gene therapy for neovascular AMD with 4D-150 with Dr. Arshad Khanani of Sierra Eye Associates and Clinical Professor of Ophthalmology at the University of Nevada Medical School, Reno.
#180
June 8 · 22 min
Home OCT in Management of Neovascular AMD
In this episode, we discuss the latest developments in the use of artificial intelligence in home OCT for management of neovascular AMD with Professor Anat Loewenstein of Tel Aviv Medical Center and President, Israeli Ophthalmology Society.
#179
June 4 · 13 min
Faricimab in the Treatment of DME: Long Term 'Results
We discuss long term results of faricimab treatment of DME, with the first author of the Ophthalmology article on the results of Rhone-X trial, Dr. Veeral Sheth, Director of Clinical Research at University Retina in Chicago.
#178
May 28 · 17 min
Xelafaslatide for the Treatment of Geographic Atrophy
In our latest episode we discuss the results of a novel approach to the treatment of geographic atrophy using Xelafaslatide a Fas inhibitor with Dr. David Zacks, Professor of Ophthalmology at the Kellogg Eye Center at the University of Michigan.
#177
May 19 · 12 min
Inhibition of IL-6 in the Treatment of Retinal Disease
In our latest episode, we discuss the use of inhibitors of IL-6 in the treatment of retinal disease with Dr. Steven M. Yeh, Stanley M. Truhlsen, Jr. , Chair of Ophthalmology a the University of Nebraska.
#176
May 12 · 14 min
Aflibercept 8mg for Retinal Vein Occlusion
In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
#175
April 29 · 7 min
Elamipretide in the Treatment of Geographic Atrophy
In this episode we discuss the results of a phase 2 trial using subcutaneous elamipretide for the treatment of geographic atrophy with Dr. Mark Barakat.
#174
April 22 · 9 min
Long Term Followup of Intravitreal Gene Therapy for Neovascular AMD
In this episode, we discuss the 3 year results of the Phase 2 trial of the Adverum intravitreal gene therapy with Dr. Dilsher Dhoot, California Retina Consultants, Adjunct Clinical Professor Ophthalmology, Keck School of Medicine of USC.

Showing 1–20 of 27 episodes